Correspondence| Volume 56, ISSUE 11, P905-906, December 01, 2004

Download started.



      Drs. Parvin and Swartz asserted that the low remission and high relapse rates we documented in a study of electroconvulsive (ECT) in major depression in community settings were due to patient selection factors. Specifically, they speculated that in community settings a substantial proportion of patients treated with ECT have the atypical subtype of depression, while melancholic and catatonic subtypes are under-represented. They also claimed that atypical depression does not respond to ECT, while melancholia and catatonia are predictive of positive outcome. They further speculated that excluding patients with a pre-ECT baseline Mini Mental State Examination (MMSE) score below 15 increases the representation of atypical depression. Finally, they claimed that we did not prove that the low rates of response and remission to ECT were due to premature ECT termination. The findings in this study contradict each of these assertions.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        The Practice of ECT. Second Edition. American Psychiatric Press, Washington, DC2001
        • Food and Drug Administration (FDA) USDHHS
        21CFR, Part 882, Neurological devices.
        Federal Register 55. 1990; 172 (September 5): 36578-36590
        • Sackeim H.A.
        • Rush A.J.
        Melancholia and response to ECT [letter].
        Am J Psychiatry. 1995; 152: 1242-1243
        • Zimmerman M.
        • Coryell. W.
        • Pfohl B.
        The treatment validity of DSM-III melancholic subtyping.
        Psychiatry Res. 1985; 16: 37-43